Targeting acetyl-CoA carboxylase 1 for cancer therapy
Metabolic adaptation is an emerging hallmark of tumors. De novo fatty acid synthesis is an important metabolic process to produce metabolic intermediates for energy storage, biosynthesis of membrane lipids and generation of signaling molecules. Acetyl-CoA carboxylase 1 (ACC1) is a critical enzyme in...
Main Authors: | Yong Yu, Qingzhu Nie, Ziyi Wang, Yu Di, Xiaolong Chen, Kaiming Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1129010/full |
Similar Items
-
Identification of Genetic Polymorphisms of PI, PIII, and Exon 53 in the Acetyl-CoA Carboxylase-α (ACACα) Gene and Their Association with Milk Composition Traits of Najdi Sheep
by: Abdulkareem M. Matar, et al.
Published: (2023-04-01) -
Acetyl-CoA Carboxylase Inhibitor CP640.186 Increases Tubulin Acetylation and Impairs Thrombin-Induced Platelet Aggregation
by: Marie Octave, et al.
Published: (2021-12-01) -
The role of acetyl-coA carboxylase2 in head and neck squamous cell carcinoma
by: Kun Li, et al.
Published: (2019-06-01) -
Acetyl-CoA Carboxylase (ACC) Inhibitor, CP640186, Effectively Inhibited Dengue Virus (DENV) Infection via Regulating ACC Phosphorylation
by: Wenyu Wu, et al.
Published: (2022-12-01) -
Alternative polyadenylation regulates acetyl-CoA carboxylase function in peanut
by: Zhenying Peng, et al.
Published: (2023-10-01)